42 related articles for article (PubMed ID: 16465413)
1. A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family.
Yang X; Shang L; Yang L; Sun L; Tuo X; Ma S; Zhao L; Li X; Yang W
Oncologist; 2024 Jun; 29(6):e837-e842. PubMed ID: 38159086
[TBL] [Abstract][Full Text] [Related]
2. Toward classification of BRCA1 missense variants using a biophysical approach.
Rowling PJ; Cook R; Itzhaki LS
J Biol Chem; 2010 Jun; 285(26):20080-7. PubMed ID: 20378548
[TBL] [Abstract][Full Text] [Related]
3. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
[TBL] [Abstract][Full Text] [Related]
4. An analysis of unclassified missense substitutions in human BRCA1.
Tavtigian SV; Samollow PB; de Silva D; Thomas A
Fam Cancer; 2006; 5(1):77-88. PubMed ID: 16528611
[TBL] [Abstract][Full Text] [Related]
5. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Seal S; Thompson D; Renwick A; Elliott A; Kelly P; Barfoot R; Chagtai T; Jayatilake H; Ahmed M; Spanova K; North B; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Nov; 38(11):1239-41. PubMed ID: 17033622
[TBL] [Abstract][Full Text] [Related]
6. The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews.
Kaufman B; Laitman Y; Carvalho MA; Edelman L; Menachem TD; Zidan J; Monteiro AN; Friedman E
Genet Test; 2006; 10(3):200-7. PubMed ID: 17020472
[TBL] [Abstract][Full Text] [Related]
7. The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon.
Buisson M; Anczuków O; Zetoune AB; Ware MD; Mazoyer S
Hum Mutat; 2006 Oct; 27(10):1024-9. PubMed ID: 16941470
[TBL] [Abstract][Full Text] [Related]
8. Pitfalls and caveats in BRCA sequencing.
Bellosillo B; Tusquets I
Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
[TBL] [Abstract][Full Text] [Related]
9. A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13.
Thomassen M; Kruse TA; Jensen PK; Gerdes AM
Genet Test; 2006; 10(2):116-20. PubMed ID: 16792514
[TBL] [Abstract][Full Text] [Related]
10. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients.
Ellis D; Patel Y; Yau SC; Hodgson SV; Abbs SJ
Fam Cancer; 2006; 5(4):323-6. PubMed ID: 16724249
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.
Pandrangi SL; Raju Bagadi SA; Sinha NK; Kumar M; Dada R; Lakhanpal M; Soni A; Malvia S; Simon S; Chintamani C; Mohil RS; Bhatnagar D; Saxena S
Cancer Cell Int; 2014 Feb; 14(1):14. PubMed ID: 24502646
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.
Son BH; Ahn SH; Kim SW; Kang E; Park SK; Lee MH; Noh WC; Kim LS; Jung Y; Kim KS; Noh DY; Moon BI; Suh YJ; Lee JE; Choi DH; Kim SY; Jung SH; Yom CK; Lee H; Yang JH;
Breast Cancer Res Treat; 2012 Jun; 133(3):1143-52. PubMed ID: 22382806
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
Kim TJ; Lee KM; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG
Oncol Rep; 2006 Mar; 15(3):565-9. PubMed ID: 16465413
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.
Kang HC; Kim IJ; Park JH; Kwon HJ; Won YJ; Heo SC; Lee SY; Kim KH; Shin Y; Noh DY; Yang DH; Choe KJ; Lee BH; King SB; Park JG
Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006
[TBL] [Abstract][Full Text] [Related]
16. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
[TBL] [Abstract][Full Text] [Related]
17. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
18. [Germ-line mutation of BRCA1 in patients with breast and/or ovarian cancer in high risk families in Northern France].
Peyrat JP; Vennin P; Hornez L; Bonneterre J
Bull Cancer; 1997 Jan; 84(1):41-6. PubMed ID: 9180858
[TBL] [Abstract][Full Text] [Related]
19. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
Kauff ND; Barakat RR
J Clin Oncol; 2007 Jul; 25(20):2921-7. PubMed ID: 17617523
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
